Trial | NCT00913783  Report issue

Title

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
Comparative, Randomized, 2-way Crossover Bioavailability Study of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules In Health Adult Males Under Fasted Conditions

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    36
To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fasted conditions.
Study Started
Nov 30
1992
Primary Completion
Dec 31
1992
Study Completion
Dec 31
1992
Last Update
Mar 28
2017

Drug Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals)

Drug Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel)

1 Experimental

Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals)

2 Active Comparator

Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel)

Criteria 

Inclusion Criteria:

No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria:

Positive test results for HIV or hepatitis B or C.
Treatment for drug or alcohol dependence.
No Results Posted